Gilvetmab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Gilvetmab
Monoclonal antibody
Type ?
Source Mouse
Target PCDC1
Clinical data
Synonyms PD1
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
Formula C6578H10212N1766O2023S48
Molar mass 147.9 g/mol

Gilvetmab (INN[1]) (PD1) is a veterinary monoclonal antibody.

This drug was developed by Merck Sharp & Dohme Corp.[2]

References[edit]